Kidder Stephen W raised its holdings in shares of Xylem Inc. (NYSE:XYL – Get Rating) by 2.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 47,499 shares of the industrial products company's stock after buying an additional 1,103 shares during the quarter. Xylem comprises about 1.4% of Kidder Stephen W's holdings, making the stock its 27th largest position. Kidder Stephen W's holdings in Xylem were worth $3,713,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Riverview Trust Co purchased a new position in Xylem during the first quarter worth about $26,000. Cyrus J. Lawrence LLC bought a new stake in Xylem during the first quarter worth about $26,000. Tompkins Financial Corp bought a new stake in Xylem during the first quarter worth about $34,000. Heritage Financial Services LLC bought a new stake in Xylem during the second quarter worth about $31,000. Finally, ACG Wealth bought a new stake in Xylem during the second quarter worth about $31,000. 84.04% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Stock Performance

Shares of NYSE XYL traded down $1.10 during midday trading on Tuesday, hitting $87.79. 10,823 shares of the stock traded hands, compared to its average volume of 1,078,345. The firm has a 50-day moving average of $93.96 and a two-hundred day moving average of $86.63. The firm has a market capitalization of $15.82 billion, a P/E ratio of 38.02, a PEG ratio of 2.88 and a beta of 1.10. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.19 and a current ratio of 1.63. Xylem Inc. has a one year low of $72.08 and a one year high of $136.15.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 29th. Investors of record on Thursday, September 1st will be issued a $0.30 dividend. The ex-dividend date is Wednesday, August 31st. This represents a $1.20 dividend on an annualized basis and a yield of 1.37%. Xylem's dividend payout ratio is currently 51.72%.

Analyst Upgrades and Downgrades

XYL has been the subject of several research analyst reports. Stifel Nicolaus raised Xylem from a "hold" rating to a "buy" rating and lifted their price target for the stock from $90.00 to $94.00 in a research note on Wednesday, July 20th. Northcoast Research initiated coverage on Xylem in a research note on Friday, July 15th. They set a "neutral" rating for the company. Morgan Stanley dropped their price target on Xylem from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Thursday, June 9th. Credit Suisse Group raised Xylem from an "underperform" rating to a "neutral" rating and boosted their target price for the company from $77.00 to $96.00 in a research note on Wednesday, August 3rd. Finally, Mizuho upped their price target on Xylem from $80.00 to $88.00 and gave the stock a "neutral" rating in a research note on Wednesday, August 3rd. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $101.64.

Insider Buying and Selling

In related news, Director Jeanne Beliveau-Dunn sold 600 shares of the firm's stock in a transaction on Thursday, August 4th. The stock was sold at an average price of $96.65, for a total value of $57,990.00. Following the transaction, the director now directly owns 7,553 shares of the company's stock, valued at approximately $729,997.45. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Xylem news, Director Victoria D. Harker sold 5,000 shares of the firm's stock in a transaction dated Wednesday, August 10th. The stock was sold at an average price of $100.26, for a total transaction of $501,300.00. Following the sale, the director now directly owns 21,099 shares of the company's stock, valued at $2,115,385.74. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Jeanne Beliveau-Dunn sold 600 shares of the firm's stock in a transaction dated Thursday, August 4th. The shares were sold at an average price of $96.65, for a total value of $57,990.00. Following the sale, the director now directly owns 7,553 shares in the company, valued at $729,997.45. The disclosure for this sale can be found here. 0.89% of the stock is owned by insiders.

About Xylem

(Get Rating)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications in the United States, Europe, the Asia Pacific, and internationally. It operates through three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions.

See Also

• Get a free copy of the StockNews.com research report on Xylem (XYL)
• Build A Better Tech Portfolio With Jabil Inc.
• Autodesk Is A Mature Company Still Acting Like A Growth Stock
• Is There Value In These Growth Stocks?
• MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
• MO Money: Why Altria Group Stock is Rallying

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Get Rating).

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.